Multiplex Antimicrobial Activities of the Self-assembled Amphiphilic Polypeptide β Nanofiber KF-5 Against Vaginal Pathogens

Overview

Journal Biol Direct

Publisher Biomed Central

Specialty Biology

Date 2024 Oct 23

PMID 39438996

Authors

Ling Fang

Tiancheng Yang

Haojue Wang

Jun Cao

Affiliations

Soon will be listed here.

Abstract

Background: Vaginal infections caused by multidrug-resistant pathogens such as Candida albicans and Gardnerella spp. represent a significant health challenge. Current treatments often fail because of resistance and toxicity. This study aimed to synthesize and characterize a novel amphiphilic polypeptide, KF-5, and evaluate its antibacterial and antifungal activities, biocompatibility, and potential mechanisms of action.

Results: The KF-5 peptide was synthesized via solid-phase peptide synthesis and self-assembled into nanostructures with filamentous and hydrogel-like configurations. Characterization by scanning electron microscopy (SEM), transmission electron microscopy (TEM), and atomic force microscopy (AFM) confirmed the unique nanostructural properties of KF-5. KF-5 (125, 250, or 500 µg/ml) demonstrated potent antibacterial and antifungal activities, with significant inhibitory effects on drug-resistant Candida albicans and Gardnerella spp. (P < 0.05). In vitro assays revealed that 500 µg/ml KF-5 disrupted microbial cell membranes, increased membrane permeability, and induced lipid oxidation, leading to cell death (P < 0.05). Cytotoxicity tests revealed minimal toxicity in human vaginal epithelial cells, keratinocytes, and macrophages, with over 95% viability at high concentrations. Molecular dynamics simulations indicated that KF-5 interacts with phospholipid bilayers through electrostatic interactions, causing membrane disruption. In vivo studies using a mouse model of vaginal infection revealed that 0.5, 1, and 2 mg/ml KF-5 significantly reduced fungal burden and inflammation, and histological analysis confirmed the restoration of vaginal mucosal integrity (P < 0.01). Compared with conventional antifungal treatments such as miconazole, KF-5 exhibited superior efficacy (P < 0.01).

Conclusions: KF-5 demonstrates significant potential as a safe and effective antimicrobial agent for treating vaginal infections. Its ability to disrupt microbial membranes while maintaining biocompatibility with human cells highlights its potential for clinical application. These findings provide a foundation for further development of KF-5 as a therapeutic option for combating drug-resistant infections.

References

Xie Y, Qin X, Zhang J, Sun M, Wang F, Huang M . Self-assembly of peptide nanofibers with chirality-encoded antimicrobial activity. J Colloid Interface Sci. 2022; 622:135-146. DOI: 10.1016/j.jcis.2022.04.058. View

Zhang H, Wei W, Zhao M, Ma L, Jiang X, Pei H . Interaction between Aβ and Tau in the Pathogenesis of Alzheimer's Disease. Int J Biol Sci. 2021; 17(9):2181-2192. PMC: 8241728. DOI: 10.7150/ijbs.57078. View

Tomas M, Palmeira-de-Oliveira A, Simoes S, Martinez-de-Oliveira J, Palmeira-de-Oliveira R . Bacterial vaginosis: Standard treatments and alternative strategies. Int J Pharm. 2020; 587:119659. DOI: 10.1016/j.ijpharm.2020.119659. View

Diez-Pascual A, Rahdar A . Functional Nanomaterials in Biomedicine: Current Uses and Potential Applications. ChemMedChem. 2022; 17(16):e202200142. PMC: 9544115. DOI: 10.1002/cmdc.202200142. View

Chen D, Liu X, Chen Y, Lin H . Amyloid peptides with antimicrobial and/or microbial agglutination activity. Appl Microbiol Biotechnol. 2022; 106(23):7711-7720. PMC: 9628408. DOI: 10.1007/s00253-022-12246-w. View

Shim D, Heo K, Kim Y, Sim E, Kang T, Choi J . Anti-Inflammatory Action of an Antimicrobial Model Peptide That Suppresses the TRIF-Dependent Signaling Pathway via Inhibition of Toll-Like Receptor 4 Endocytosis in Lipopolysaccharide-Stimulated Macrophages. PLoS One. 2015; 10(5):e0126871. PMC: 4446091. DOI: 10.1371/journal.pone.0126871. View

Habibi N, Kamaly N, Memic A, Shafiee H . Self-assembled peptide-based nanostructures: Smart nanomaterials toward targeted drug delivery. Nano Today. 2016; 11(1):41-60. PMC: 4834907. DOI: 10.1016/j.nantod.2016.02.004. View

Bourgade K, Garneau H, Giroux G, Le Page A, Bocti C, Dupuis G . β-Amyloid peptides display protective activity against the human Alzheimer's disease-associated herpes simplex virus-1. Biogerontology. 2014; 16(1):85-98. DOI: 10.1007/s10522-014-9538-8. View

Hafeez A, Jiang X, Bergen P, Zhu Y . Antimicrobial Peptides: An Update on Classifications and Databases. Int J Mol Sci. 2021; 22(21). PMC: 8583803. DOI: 10.3390/ijms222111691. View

10.

Harriott M, Noverr M . Importance of Candida-bacterial polymicrobial biofilms in disease. Trends Microbiol. 2011; 19(11):557-63. PMC: 3205277. DOI: 10.1016/j.tim.2011.07.004. View

11.

Park I, Jailani A, Lee J, Ahmed B, Lee J . The Antibiofilm Effects of Antimony Tin Oxide Nanoparticles against Polymicrobial Biofilms of Uropathogenic and . Pharmaceutics. 2023; 15(6). PMC: 10301033. DOI: 10.3390/pharmaceutics15061679. View

12.

Chung P, Khanum R . Antimicrobial peptides as potential anti-biofilm agents against multidrug-resistant bacteria. J Microbiol Immunol Infect. 2017; 50(4):405-410. DOI: 10.1016/j.jmii.2016.12.005. View

13.

Hess B, Kutzner C, van der Spoel D, Lindahl E . GROMACS 4: Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation. J Chem Theory Comput. 2015; 4(3):435-47. DOI: 10.1021/ct700301q. View

14.

Qi G, Gao Y, Wang L, Wang H . Self-Assembled Peptide-Based Nanomaterials for Biomedical Imaging and Therapy. Adv Mater. 2018; 30(22):e1703444. DOI: 10.1002/adma.201703444. View

15.

Fischer T, Klein R, Kershnar H, Borut T, Stiehm E . Miconazole in the treatment of chronic mucocutaneous candidiasis: a preliminary report. J Pediatr. 1977; 91(5):815-9. DOI: 10.1016/s0022-3476(77)81050-0. View

16.

Greenbaum S, Greenbaum G, Moran-Gilad J, Weintraub A . Ecological dynamics of the vaginal microbiome in relation to health and disease. Am J Obstet Gynecol. 2018; 220(4):324-335. DOI: 10.1016/j.ajog.2018.11.1089. View

17.

Chu H, Pazgier M, Jung G, Nuccio S, Castillo P, de Jong M . Human α-defensin 6 promotes mucosal innate immunity through self-assembled peptide nanonets. Science. 2012; 337(6093):477-81. PMC: 4332406. DOI: 10.1126/science.1218831. View

18.

Abou Chacra L, Fenollar F, Diop K . Bacterial Vaginosis: What Do We Currently Know?. Front Cell Infect Microbiol. 2022; 11:672429. PMC: 8805710. DOI: 10.3389/fcimb.2021.672429. View

19.

White M, Kandel R, Tripathi S, Condon D, Qi L, Taubenberger J . Alzheimer's associated β-amyloid protein inhibits influenza A virus and modulates viral interactions with phagocytes. PLoS One. 2014; 9(7):e101364. PMC: 4079246. DOI: 10.1371/journal.pone.0101364. View

20.

Kumar D, Choi S, Washicosky K, Eimer W, Tucker S, Ghofrani J . Amyloid-β peptide protects against microbial infection in mouse and worm models of Alzheimer's disease. Sci Transl Med. 2016; 8(340):340ra72. PMC: 5505565. DOI: 10.1126/scitranslmed.aaf1059. View